메뉴 건너뛰기




Volumn 15, Issue 6, 2000, Pages 430-431

Decision analytic modeling and NSAID gastropathy: Could we be more sensitive?

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

EID: 0033920333     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.2000.0004009.x     Document Type: Editorial
Times cited : (4)

References (5)
  • 1
    • 0025998097 scopus 로고
    • Risk for serious gastrointestinal complications related to use of NSAIDS: a meta-analysis
    • 1. SE Gabriel L Jaakkimainen C Bombardier 1991 Risk for serious gastrointestinal complications related to use of NSAIDS: a meta-analysis Ann Intern Med 115 787 96 1834002 1:STN:280:By2D38jitlE%3D Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of NSAIDS: a meta-analysis. Ann Intern Med. 1991;115:787–96.
    • (1991) Ann Intern Med , vol.115 , pp. 787-96
    • Gabriel, SE1    Jaakkimainen, L2    Bombardier, C3
  • 2
    • 0033577982 scopus 로고    scopus 로고
    • Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
    • 2. MM Wolfe D Lichtenstein G Singh 1999 Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs N Engl J Med 340 24 1888 99 10369853 10.1056/NEJM199906173402407 1:CAS:528:DyaK1MXktFKrtbs%3D Wolfe MM, Lichtenstein D, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340(24):1888–99.
    • (1999) N Engl J Med , vol.340 , Issue.24 , pp. 1888-99
    • Wolfe, MM1    Lichtenstein, D2    Singh, G3
  • 3
    • 0029738533 scopus 로고    scopus 로고
    • Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs
    • 3. WE Smalley MR Griffin RL Fought WA Ray 1996 Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs J Gen Intern Med 11 461 9 8872783 10.1007/BF02599040 1:STN:280:ByiD38nmtVE%3D Smalley WE, Griffin MR, Fought RL, Ray WA. Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs. J Gen Intern Med. 1996;11:461–9.
    • (1996) J Gen Intern Med , vol.11 , pp. 461-9
    • Smalley, WE1    Griffin, MR2    Fought, RL3    Ray, WA4
  • 4
    • 0033945204 scopus 로고    scopus 로고
    • Cost-effectiveness of different strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease
    • 4. CW Ko RA Deyo 2000 Cost-effectiveness of different strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease J Gen Intern Med 15 400 410 10886475 10.1046/j.1525-1497.2000.03459.x 1:STN:280:DC%2BD3czpsleqsw%3D%3D Ko CW, Deyo RA. Cost-effectiveness of different strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease. J Gen Intern Med. 2000;15:400–410.
    • (2000) J Gen Intern Med , vol.15 , pp. 400-410
    • Ko, CW1    Deyo, RA2
  • 5
    • 0033601789 scopus 로고    scopus 로고
    • Clinical and economic effects on population-based Helicobacter pylori screening to prevent gastric cancer
    • 5. AM Fendrick ME Chernew RA Hirth BS Bloom RR Bandekar JM Scheiman 1999 Clinical and economic effects on population-based Helicobacter pylori screening to prevent gastric cancer Arch Intern Med 159 142 8 9927096 10.1001/archinte.159.2.142 1:STN:280:DyaK1M7isVartA%3D%3D Fendrick AM, Chernew ME, Hirth RA, Bloom BS, Bandekar RR, Scheiman JM. Clinical and economic effects on population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med. 1999;159:142–8.
    • (1999) Arch Intern Med , vol.159 , pp. 142-8
    • Fendrick, AM1    Chernew, ME2    Hirth, RA3    Bloom, BS4    Bandekar, RR5    Scheiman, JM6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.